Technology Transfer And Scale-Up
Research & Development
Innovation is the foundation of our pharmaceutical research and development. We are committed to developing high quality advanced generic medicine with better therapeutic safety, efficacy and complexity. Thereby bringing greater access the worlds best and safest therpies.
Our R&D team combines scientific expertise with advanced technologies to develop safe, effective, and high-quality formulations. Every stage of development—from concept and formulation to analytical testing, process optimization, and technology transfer—is carried out with a strong focus on quality, regulatory compliance, and patient well-being.
Our Core Capabilities
Regulatory Documentation Support
Formulation And Product Development
Continuous Product Improvement And Lifecycle Management
Process Development And Optimization
Analytical Method Development And Validation
Stability Studies And Quality Evaluation
Technology Transfer And Scale-Up
Regulatory Documentation Support
Formulation And Product Development
Continuous Product Improvement And Lifecycle Management
Process Development And Optimization
Analytical Method Development And Validation
Stability Studies And Quality Evaluation
R&D Infrastructure
Formulation And Product Development
Our Formulation Development Laboratory (FDL) develops robust and scalable formulations across tablets, sterile and non-sterile semi-solids, and small-volume injectables. Development is guided by product performance, quality-by-design principles, process understanding, stability requirements and the needs of the intended market.
Analytical Method Development And Validation
Our Analytical Development Laboratory (ADL) develops and validates reliable analytical methods to establish the identity, strength, quality, purity and performance of our products. The laboratory supports formulation development, comparative studies, stability evaluation, method transfer and regulatory documentation throughout the product lifecycle.
Development Achievements
Our development capabilities are reflected in products that demonstrate performance comparable to established reference medicines. Selected comparative in vitro studies, including dissolution profile evaluations, illustrate the scientific approach and product understanding applied during development.
From Development to Commercialization
Our work extends beyond successful laboratory development. The products showcased below represent formulations that have progressed through scale-up, regulatory review and commercial manufacturing—turning scientific concepts into accessible medicines for patients across multiple markets.
